The JUvaLIfe Registry
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 2,000
- 试验地点
- 4
- 主要终点
- Reduction in reliance on Rx medications
研究概览
简要总结
The JuLi Registry seeks to fill some of the gaps associated with the clinical use of CBD (cannabidiol) and other cannabinoid formulations including THC and others. The overarching goal of this Registry is to rapidly advance research and understanding of the use of cannabis and hemp-based formulations, in the clinical community setting, when it is utilized to manage the symptoms of cancer treatment and other underlying health issues. These symptoms include nausea, neuropathy, and sleeplessness and chronic pain.
详细描述
The JuLi Registry seeks to fill some of the gaps associated with the clinical application of CBD (cannabidiol) and other cannabinoid formulations including THC and others. It will also serve as a platform for discovery, whereby observations of patient symptoms, specific cannabis formulations, delivery methods and clinical outcomes, become the source of more in-depth research projects.
The JuLi Registry is a prospective observational Registry documenting utility and patient experience for patients seeking to use therapeutic cannabis and hemp-based products as a means of symptom relief and management related to various diseases.
Targeted symptoms and conditions include:
- Chronic Pain
- Neuropathy
- Sleeplessness
- Poor Appetite
- Nausea
- Anxiety
- Menopausal symptoms
Data to be recorded includes:
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 21 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •21 years of age or older
- •Have requested from and/or decided with their providers to try CBD (hemp-based) or other cannabis products to relieve one or more symptoms related to a medical diagnosis
- •Consent to have their health data included in a Registry and participate in PRO (patient reported outcomes) surveys and data collection via a study app.
排除标准
- •Patient pregnant
- •Unwilling or unable to provide informed consent
结局指标
主要结局
Reduction in reliance on Rx medications
时间窗: 3 months
Percentage of patients who report reduction or increase in use of Rx medications
Symptom Relief
时间窗: 3 months
Percentage of patients who obtain and report symptom relief, by symptom, condition and cannabis formulation
次要结局
- Reduction in reliance on OTC medications(3 months)